Fresenius Medical Care hires Carla Kriwet to replace CEO Rice Powell

Carla Kriwet becomes CEO of Fresenius Medical Care [Photo courtesy of Fresenius]

Fresenius Medical Care (NYSE: FMS) has hired Carla Kriwet as its next CEO effective January 1, 2023.

Kriwet will replace Rice Powell, who will step down on Dec. 31 after reaching the company’s age limit. Powell is 66 years old. Kriwet is 51 years old.

“I fully identify with the vision of making the lives of patients who trust us a little more worth living every day,” Kriwet said in a press release yesterday. “And I believe that bringing ever better medicines to ever more people goes hand in hand with economic success.”

Fresenius CFO and CTO Helen Giza will assume the role of Deputy CEO and enter into a new 5-year employment contract, the company said.

Kriwet served as CEO and President of BSH Hausgeräte (Home Appliances) GmbH from July 2020 until stepping down at the end of last month. During this period, BSH – which has around 62,000 employees and 40 production plants – has recorded two consecutive years of record sales, reaching 15.6 billion euros in 2021.

“Carla has led BSH very successfully through the difficult phase of the pandemic and the many challenges associated with it,” BSH Supervisory Board Chairman Christian Fischer said in a press release.

Prior to BSH, Kriwet spent seven years at Royal Philips, eventually leading the Connected Care division as CEO and serving on the company’s executive committee.

Powell joined Fresenius in 1997 and became CEO in 2013. Fresenius Medical Care credits him for identifying value-based care and home dialysis as emerging business trends early enough to successfully expand there. .

“I look back with great gratitude and pride at what we have accomplished during this time,” he said in the press release. “Our products and services are more important than ever to our patients and an integral part of their lives. As the world’s only provider of a full range of innovative therapies and products for people with kidney disease, we have exceptional prerequisites for our continued success. I would like to thank all my colleagues… I am very happy to know that our company will be in good hands in the future.

Fresenius provides dialysis treatment to approximately 345,000 patients at 4,171 dialysis clinics worldwide. It is one of the largest medical technology companies in the world, ranking 28th in the Medtech Big 100 2021 ranking.


Source link